Table 5.
Placebo-induced reductions | Name | x | y | z | Voxels | Studies active (%) |
---|---|---|---|---|---|---|
Height-corrected FWE p < 0.05 | Insula, L Anterior | −38 | −2 | −16 | 60 | 31.67 |
−44 | −4 | −8 | 95 | 31.67 | ||
−42 | −18 | 2 | 65 | 32.62 | ||
Insula, L Middle | −36 | −10 | −4 | 153 | 46.35 | |
−34 | 4 | −4 | 249 | 49.83 | ||
−40 | −6 | 6 | 310 | 49.83 | ||
Extent-corrected p < 0.001 | dpIns, L (OP4)/Heschl’s Gyrus | −48 | −16 | 10 | 141 | 36.1 |
Insula, L Anterior (BA44) | −42 | 10 | 2 | 82 | 36.92 | |
Putamen, L | −26 | −12 | 2 | 66 | 53.69 | |
Putamen, L, contiguous with L Anterior Insula | −30 | 14 | −2 | 241 | 33.44 | |
Amygdala, L | −26 | −6 | −10 | 159 | 39.01 | |
Amygdala, L, contiguous with L Putamen | −26 | 4 | −12 | 161 | 26.1 | |
Insula, L Anterior | −38 | 8 | −14 | 141 | 31.67 |
This table reports clusters and contiguous subclusters corresponding to Fig. 3a